DiaSorin (ISIN IT0003497168) is a global player in the in-vitro diagnostics market, supplying laboratories with tests and instruments used to detect infectious diseases, monitor chronic conditions and support personalized medicine decisions. The company is listed in Italy and has built a broad international footprint, giving investors exposure to long-term growth in healthcare spending and diagnostic testing.
Global diagnostics specialist
DiaSorin focuses on specialty tests in areas such as infectious disease, autoimmune disorders,…
